‘We need positive destruction’: Yale doctors discuss gender equity on Clubhouse
Inginia Genao, MD, kicked off a recent Clubhouse discussion on gender equity in medicine with a sobering statistic: research shows that nearly 40% of women become part time or leave medicine within six years of completing their residency. The discussion, held May 13, was hosted by the Yale Department of Internal Medicine.
Save the Dates: IEEE Games, Entertainment, and Media Conference, June 19-22
The IEEE Games, Entertainment and Media (GEM) conference will be taking place at Yale University between June 19 and 22. This year’s conference will include a new platform for the exhibition of performances and experiences that utilize the emerging fields of Motion Capture, Virtual Reality, and Augmented Reality with a particular emphasis on pedagogy in these areas.
Proctor and Gorelick Win AGA Awards
Deborah D. Proctor, MD, AGAF, professor of medicine (digestive diseases) and medical director, Inflammatory Bowel Disease Program and Fred S. Gorelick, MD, Henry J. and Joan W. Binder Professor of Medicine (Digestive Diseases) and of Cell Biology and deputy director, Yale MD-PhD Program won 2019 American Gastroenterological Association (AGA) Recognition Awards, given in honor of outstanding contributions and achievements in gastroenterology.
Krumholz, Spatz receive funding to develop new 24/7 blood pressure monitor
The National Institute of Biomedical Imaging and Bioengineering has awarded a $1.2 million, four-year grant to investigators at Texas A&M University and Yale University for the development of a wrist-worn, cuffless blood pressure monitoring system.
Medical faculty elected to the American Society for Clinical Investigation
Drs. Daniel Greif, Cary Gross, Chirag Parikh, and Joseph Ross of Yale School of Medicine have been elected to the American Society for Clinical Investigation (ASCI). One of the nation’s oldest and most prestigious medical honor societies, ASCI supports the work of top physician-scientists whose research improves human health.
Videogame boosts sex health IQ and attitudes in minority teens
A videogame designed by Yale researchers to promote health and reduce risky behavior in teens improves sexual health knowledge and attitudes among minority youth, according to a new study. The findings validate the value of the videogame as a tool to engage and educate teens at risk for HIV and other sexually transmitted infections (STIs), said the researchers.
Yale center’s event ‘For a Girl’ empowers young women
It was fun, and there were games, but the two-week “For a Girl” program was mostly about empowering young women to do and be whatever they dream. Sponsored by Dr. Lynn Fiellin’s play2PREVENT Lab at the Yale Center for Health and Learning Games, nine girls heard life stories from successful female faculty members at the Yale School of Medicine and elsewhere at the university and designed video games that were meant to educate, not entertain. The three teams presented their games on Friday.Source: New Haven Register
Seeking better health: Yale and New Haven
In the early 1970s, Maria Melendez, recently arrived from Puerto Rico, saw that there were no Spanish-speaking doctors serving her new neighborhood of Fair Haven. With others in the community as well as local groups, she launched a campaign that led first to nursing visits and then to the establishment of the Fair Haven Community Health Center.Source: Yale Medicine
Fiellin to head Yale College program to curb harm from alcohol, drugs
Dr. Lynn Fiellin has been appointed as director of the Alcohol and Other Drug Harm Reduction Initiative (AODHRI) at Yale College, according an announcement by Dean Jonathan Holloway. Fiellin, who assumed her new role on June 1, is an associate professor of medicine in the Department of Internal Medicine and the Yale Child Study Center. She is founder and director of the play2PREVENT Lab at the Yale Center for Health & Learning Games, a program at the School of Medicine in which she and her team develop and evaluate evidence-based videogame interventions for health and education in youth and young adults.Source: YaleNews
Yale Study: Minority Breast Cancer Patients Less Likely To Have Genetic Test
A genetic test that helps doctors determine how best to treat breast cancer—and whether chemotherapy is likely to help—is significantly more likely to be administered to white women than blacks or Hispanics, a Yale study has found.Source: Connecticut Health I-Team
Racial Disparities in Genetic Testing of Women With Breast Cancer
MedicalResearch.com Interview with: Cary P. Gross, MD Section of General Internal Medicine Yale University School of Medicine New Haven, CT MedicalResearch.com: What is the background for this study? What are the main findings? Response: Prior work has demonstrated racial and socioeconomic disparities in breast cancer diagnosis, treatment, and outcomes. As the oncology field has progressed over the past decade, the use of genetic testing to guide treatment decisions is one of the most exciting new developments.Source: Medical Research
Yale Study Published in JNCCN Uncovers Racial Disparities in Treatment of Women with Breast Cancer
In a simple definition, cancer is a disease of the cells, which is caused by gene mutations. For a proportion of patients, including women with hormone receptor positive (HR+) breast cancer, gene expression profiling has a substantial impact on treatment decision-making by determining which patients might—or might not—respond to particular treatment options.
Yale Cancer Center wins grant to improve care for metastatic breast cancer patients
A proposal for improving the partnership between metastatic breast cancer patients and their medical care teams has garnered Yale Cancer Center and Smilow Cancer Hospital at Yale-New Haven a $358,000 award from the National Comprehensive Cancer Network (NCCN) in collaboration with Pfizer. Only ten awards were given to cancer centers around the country.